相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Kasthuri Kannan et al.
Oncotarget (2015)
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Jinghui Zhang et al.
NATURE GENETICS (2013)
CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2012)
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Xiao-Yang Liu et al.
ACTA NEUROPATHOLOGICA (2012)
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
Stephen Yip et al.
JOURNAL OF PATHOLOGY (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
Shwetal Mehta et al.
CANCER CELL (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Phosphorylation State of Olig2 Regulates Proliferation of Neural Progenitors
Yu Sun et al.
NEURON (2011)
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
Chetan Bettegowda et al.
SCIENCE (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
Molecular Classification of Low-Grade Diffuse Gliomas
Young Ho Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
David Capper et al.
BRAIN PATHOLOGY (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes
Sjef Copray et al.
STEM CELLS (2006)
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification
K Mokhtari et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas
KL Ligon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors
L Aguirre-Cruz et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Anti-human olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas
H Yokoo et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
The basic helix-loop-helix factor Olig2 is essential for the development of motoneuron and oligodendrocyte lineages
H Takebayashi et al.
CURRENT BIOLOGY (2002)
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas
T Watanabe et al.
ACTA NEUROPATHOLOGICA (2002)
The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2
Q Zhou et al.
NEURON (2001)
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors
QR Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
